Table 6.
Program component | Treatment mean | Control mean | Impact | p-Value | Adjusted p-value | Sample size |
---|---|---|---|---|---|---|
In previous 12 months, exposed to information on | ||||||
Relationships | 17.82 | 20.84 | − 3.02 | 0.680 | 1.000 | 221 |
Parenting | 68.24 | 44.60 | 23.65 | 0.010 | 0.043 | 220 |
Child health care | 57.28 | 52.63 | 4.65 | 0.614 | 0.999 | 221 |
Education related services | 29.44 | 28.80 | 0.64 | 0.930 | 1.000 | 220 |
Career Counseling or job training | 18.54 | 22.05 | − 3.51 | 0.624 | 0.976 | 220 |
Methods of birth control | 84.70 | 67.22 | 17.48 | 0.024 | 0.114 | 217 |
Percent correct on assessments of knowledge of contraception | ||||||
Condoms | 58.55 | 61.09 | − 2.54 | 0.470 | 0.920 | 220 |
Birth control pills | 45.08 | 55.14 | − 10.06 | 0.050 | 0.144 | 220 |
IUDs | 35.38 | 34.87 | 0.51 | 0.904 | 1.000 | 220 |
Other methods | 37.11 | 36.70 | 0.41 | 0.923 | 1.000 | 220 |
Treatment and control group means are regression adjusted. Impacts on binary outcomes are estimated using a two-stage least squares model instrumenting for program participation using treatment status, with standard errors adjusted to account for heteroskedasticity. Regressions control for all baseline characteristics and stratum in addition to treatment status. All p-values are based on a two-sided test, and adjusted p-values control for the familywise error rate using the method in Hothorn et al. (2008). Sample sizes differ across outcomes due to missing outcome data. Source: Baseline survey and 12 month follow-up survey
*Significantly different from zero at the .10 level after adjusting for multiple comparisons, two-tailed test
**Significantly different from zero at the .05 level after adjusting for multiple comparisons, two-tailed test
***Significantly different from zero at the .01 level after adjusting for multiple comparisons, two-tailed test